RxDoctor Payments Data

Emily Bowden

Obstetrics · Houston, TXNPI 1588197966

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 25.3% of the total. Reporting peaked in 2023 at $552 and has fallen 83.3% since, to $92 in 2024. That places this record below the midpoint for obstetrics clinicians in TX, where the typical reported total is $1,137.

$865in general payments, 2019–2025

Across 37 payments — averaging $23.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$219
  • Hologic Sales And Service, LLC$184
  • Relievant Medsystems, Inc.$135
  • Daiichi Sankyo Inc.$115
  • Therapeuticsmd, Inc.$44
  • Organon$35
  • plus $133 from 7 others

What the payments were for

  • Food & beverage$865100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$865 in reported general payments places this provider in the 45th percentile of 85 obstetrics providers in Texas.

See all obstetrics providers in Texas

Medicare billing

Part B allowed, 2024
$8,166
Medicare patients
29
Services billed
227

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated12$5,003
Estradiol26$1,323
ProgesteroneProgesterone, Micronized23$526
Clobetasol Propionate12$245
Alendronate Sodium12$189

Paid to pharmacies, not to this prescriber.

Other obstetrics in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →